Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
3.665
+0.095 (2.66%)
At close: May 30, 2025, 4:00 PM
3.660
-0.005 (-0.14%)
After-hours: May 30, 2025, 4:04 PM EDT

Contineum Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
95378---
Enterprise Value
-90164---
Last Close Price
3.6614.65---
Debt / Equity Ratio
0.030.030.010.150.08
Debt / EBITDA Ratio
--0.03--
Debt / FCF Ratio
--0.03--
Asset Turnover
--0.55--
Quick Ratio
21.3120.5322.836.2618.78
Current Ratio
21.4720.6923.296.4118.99
Return on Equity (ROE)
-33.03%-26.19%27.71%-48.09%-
Return on Assets (ROA)
-22.95%-18.54%11.10%-23.44%-
Return on Capital (ROIC)
-23.95%-19.30%11.79%-25.44%-
Return on Capital Employed (ROCE)
--12.90%--
Buyback Yield / Dilution
-981.89%-469.95%-51.38%-6.35%-
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q